Skip to content

Clinical trials

Carcinoma, Transitional Cell trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Country / region: Belgium Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20083
20132
20152
20163
20175
20184
20195
20202
20213
20224
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Active, not recruiting7
Terminated6
Recruiting4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation4
Bristol-Myers Squibb3
EMD Serono Research & Development Institute, Inc.3
Hoffmann-La Roche3
Cliniques universitaires Saint-Luc- Université Catholique de Louvain2
Daiichi Sankyo2
Exelixis2
Genentech, Inc.2
Nektar Therapeutics2
Seagen, a wholly owned subsidiary of Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell38
Carcinoma, Non-Small-Cell Lung12
Urinary Bladder Neoplasms12
Carcinoma, Renal Cell11
Colorectal Neoplasms9
Neoplasm Metastasis9
Carcinoma, Hepatocellular8
Melanoma8
Squamous Cell Carcinoma of Head and Neck8
Endometrial Neoplasms5

Trials

Showing 76 to 38 of 38. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.